This is a 1-year follow-up study to evaluate the long-term effects in subjects who
completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The
1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a
placebo cream for the treatment of AK.
- Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK
- Did not use any topical preparations in the previous treatment area within 24-hours
of the scheduled visit.